FDA Approves New Drug for Acute Pancreatitis Prevention

The FDA has granted approval to Tryngolza, a novel treatment from Ionis Pharmaceuticals, designed to lower the risk of acute pancreatitis in adults with severe hypertriglyceridemia. This marks the first approved therapy specifically for this preventative purpose. The drug received both Priority Review and Breakthrough Therapy designations, underscoring its significance.